Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nL-SCN2A-002 in SCN2A-associated DEE
NCT06314490Phase 2Active, not recruiting
- Sponsor
- University of California, San Diego
- Start
- Feb 2024
- Primary completion
- Feb 2026
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of nL-SCN2A-002 in SCN2A-related developmental and epileptic encephalopathy (SCN2A-DEE), sponsored by University of California, San Diego. Started Feb 2024; status: active, not recruiting.
02
Drugs
nL-SCN2A-002
03
Conditions
SCN2A-related developmental and epileptic encephalopathy (SCN2A-DEE)
Beyond the preview
Go deeper on NCT06314490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314490.